183 related articles for article (PubMed ID: 9877002)
1. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
Buchwald A; Hochhaus G
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol: a novel, long-acting beta 2-agonist.
Meyer JM; Wenzel CL; Kradjan WA
Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
Brogden RN; Faulds D
Allergol Immunopathol (Madr); 1992; 20(2):72-84. PubMed ID: 1359777
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta 2-agonists. Role in primary care asthma treatment.
D'Urzo AD
Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of salmeterol.
Cazzola M; Testi R; Matera MG
Clin Pharmacokinet; 2002; 41(1):19-30. PubMed ID: 11825095
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta 2-agonists.
Tattersfield AE
Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
[No Abstract] [Full Text] [Related]
10. [Long-acting beta-2-agonists in the treatment of asthma].
Rochat T
Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
[TBL] [Abstract][Full Text] [Related]
11. [The effect of salmeterol on aspirin-induced asthma and on smell].
Mihălţan F; Muir P; Muir JF
Rom J Intern Med; 1994; 32(3):235-8. PubMed ID: 7866341
[No Abstract] [Full Text] [Related]
12. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol: a long acting bronchodilator.
Bhadoria DP; Bhadoria P
J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700
[No Abstract] [Full Text] [Related]
14. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
Berger WE
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
[TBL] [Abstract][Full Text] [Related]
15. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of inhalatory beta2-mimetics with long-term action (formoterol vs. salmeterol)].
Kollár P; Kotolová H
Ceska Slov Farm; 2006 Sep; 55(5):230-5. PubMed ID: 17128593
[TBL] [Abstract][Full Text] [Related]
17. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
[TBL] [Abstract][Full Text] [Related]
18. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of long-acting beta-receptor agonists.
Tattersfield AE
Life Sci; 1993; 52(26):2161-9. PubMed ID: 8099697
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol.
Ind PW
Br J Hosp Med; 1990 Nov; 44(5):343-4. PubMed ID: 1980426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
